J.C. Fruchart

2.2k total citations
44 papers, 1.9k citations indexed

About

J.C. Fruchart is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, J.C. Fruchart has authored 44 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 17 papers in Molecular Biology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in J.C. Fruchart's work include Lipoproteins and Cardiovascular Health (12 papers), Peroxisome Proliferator-Activated Receptors (10 papers) and Cancer, Lipids, and Metabolism (8 papers). J.C. Fruchart is often cited by papers focused on Lipoproteins and Cardiovascular Health (12 papers), Peroxisome Proliferator-Activated Receptors (10 papers) and Cancer, Lipids, and Metabolism (8 papers). J.C. Fruchart collaborates with scholars based in France, United States and Germany. J.C. Fruchart's co-authors include Bart Staels, Jean‐Marie Bard, Catherine Fiévet, Marie‐Pierre Dehouck, José M. Ordovás, Corine Glineur, Olivier Barbier, Christophe Blanquart, Yannick Duguay and Dean W. Hum and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Circulation Research.

In The Last Decade

J.C. Fruchart

42 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.C. Fruchart France 18 867 656 611 289 281 44 1.9k
Anne Minnich United States 20 1.1k 1.3× 834 1.3× 433 0.7× 360 1.2× 325 1.2× 34 2.1k
J.C. Fruchart France 21 1.4k 1.6× 934 1.4× 741 1.2× 316 1.1× 590 2.1× 60 2.6k
Arnold D. Essenburg United States 20 679 0.8× 692 1.1× 372 0.6× 321 1.1× 205 0.7× 34 1.6k
Masakazu Sakai Japan 24 677 0.8× 736 1.1× 392 0.6× 152 0.5× 281 1.0× 50 1.9k
Uday Saxena United States 26 649 0.7× 542 0.8× 698 1.1× 214 0.7× 338 1.2× 54 2.1k
Mark C. Kowala United States 24 640 0.7× 618 0.9× 273 0.4× 362 1.3× 210 0.7× 56 1.9k
D Pometta Switzerland 21 358 0.4× 560 0.9× 738 1.2× 212 0.7× 201 0.7× 77 1.9k
Patrick I. Eacho United States 28 1.3k 1.5× 1.1k 1.6× 519 0.8× 317 1.1× 436 1.6× 61 2.7k
Willeke de Haan Netherlands 22 522 0.6× 809 1.2× 491 0.8× 209 0.7× 261 0.9× 31 1.7k
Lauren M. Cagen United States 21 734 0.8× 459 0.7× 251 0.4× 326 1.1× 159 0.6× 47 1.8k

Countries citing papers authored by J.C. Fruchart

Since Specialization
Citations

This map shows the geographic impact of J.C. Fruchart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.C. Fruchart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.C. Fruchart more than expected).

Fields of papers citing papers by J.C. Fruchart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.C. Fruchart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.C. Fruchart. The network helps show where J.C. Fruchart may publish in the future.

Co-authorship network of co-authors of J.C. Fruchart

This figure shows the co-authorship network connecting the top 25 collaborators of J.C. Fruchart. A scholar is included among the top collaborators of J.C. Fruchart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.C. Fruchart. J.C. Fruchart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rubenstrunk, A., Rémy Hanf, Dean W. Hum, J.C. Fruchart, & Bart Staels. (2007). Safety issues and prospects for future generations of PPAR modulators. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1771(8). 1065–1081. 244 indexed citations
2.
Billiet, Ludivine, Christophe Furman, Guilhem Larigauderie, et al.. (2007). Enhanced VDUP‐1 gene expression by PPARγ agonist induces apoptosis in human macrophage. Journal of Cellular Physiology. 214(1). 183–191. 28 indexed citations
3.
Fiévet, Catherine, J.C. Fruchart, & Bart Staels. (2006). PPARα and PPARγ dual agonists for the treatment of type 2 diabetes and the metabolic syndrome. Current Opinion in Pharmacology. 6(6). 606–614. 163 indexed citations
4.
Fontaine, Coralie, et al.. (2005). Fibrates. Handbook of experimental pharmacology. 389–406. 15 indexed citations
5.
Dallongeville, Jean, Eric Baugé, P. Lebel, & J.C. Fruchart. (1997). Fat ingestion is associated with increased levels of apoC‐III‐ and apoE‐B‐containing lipoprotein particles in humans. European Journal of Clinical Investigation. 27(12). 1055–1060. 10 indexed citations
6.
Luc, G., Jean‐Marie Bard, Philippe Poulain, et al.. (1997). Relationship between low‐density lipoprotein size and apolipoprotein A‐I‐containing particles: the ECTIM study. European Journal of Clinical Investigation. 27(3). 242–247. 2 indexed citations
7.
Vu‐Dac, Ngoc, et al.. (1996). Involvement of intronic sequences in the transcriptional regulation of apolipoprotein B, E and A-II genes.. PubMed. 34 Suppl 3. 44–5. 2 indexed citations
8.
Istad, Helge, Leiv Ose, Egil Bodd, et al.. (1994). Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramine. European Journal of Clinical Pharmacology. 46(5). 445–9. 22 indexed citations
9.
Feillet, François, et al.. (1993). Lipoprotein metabolism in marasmic children of Northern Mauritania. American Journal of Clinical Nutrition. 58(4). 484–488. 22 indexed citations
10.
Chesné, Christophe, M. P. Dehouck, Françoise Brée, et al.. (1993). Drug Transfer Across the Blood-Brain Barrier: Comparison of in Vitro and in Vivo Models. Advances in experimental medicine and biology. 331. 113–115. 9 indexed citations
11.
Genest, Jacques, Jean‐Marie Bard, J.C. Fruchart, José M. Ordovás, & Ernst J. Schaefer. (1993). Familial hypoalphalipoproteinemia in premature coronary artery disease.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 13(12). 1728–1737. 101 indexed citations
12.
Duchâteau, Philippe, Daniel J. Rader, Nicolas Duverger, et al.. (1993). Tangier disease: isolation and characterization of LpA-I, LpA-II, LpA-I:A-II and LpA-IV particles from plasma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1182(1). 30–35. 13 indexed citations
13.
Fruchart, J.C.. (1992). High-Density Lipoprotein Particles, Nutrition and Arteriosclerosis. Forum of nutrition/Bibliotheca Nutritio et dieta. 66–78. 1 indexed citations
14.
Fruchart, J.C. & Gérard Ailhaud. (1992). Apolipoprotein A-Containing Lipoprotein Particles: Physiological Role, Quantification, and Clinical Significance. Clinical Chemistry. 38(6). 793–797. 88 indexed citations
15.
16.
Bard, Jean‐Marie, H J Parra, P Douste‐Blazy, & J.C. Fruchart. (1990). Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition. Metabolism. 39(3). 269–273. 46 indexed citations
17.
Lesieur, Daniel, et al.. (1989). Lipid lowering actions of 7-(2-methylene butyryl)-(2H)-1,4-benzoxazin-3-(4H)-one derivatives in mice, rats and Syrian hamsters. Clinica Chimica Acta. 180(1). 35–44. 11 indexed citations
18.
Olivier, Patrick, et al.. (1988). Effects of fenofibrate on lipoprotein metabolism and fatty acid distribution in Zucker rats. Atherosclerosis. 74(1-2). 15–21. 14 indexed citations
19.
Bétard, Christine, et al.. (1987). Standardization of an Enzymometric Assay for Apolipoprotein A-I by Using Mixtures of Monoclonal Antibodies. Clinical Chemistry and Laboratory Medicine (CCLM). 25(12). 893–9. 24 indexed citations
20.
Dewailly, P, et al.. (1975). Etude métabolique de trois émulsions lipidiques utilisées dans l’alimentation parentérale. Annals of Nutrition and Metabolism. 19(5-6). 318–326. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Minnich Breakdown of academic impact, for papers by J.C. Fruchart Breakdown of academic impact, for papers by Arnold D. Essenburg Breakdown of academic impact, for papers by Masakazu Sakai Breakdown of academic impact, for papers by Uday Saxena Breakdown of academic impact, for papers by Mark C. Kowala Breakdown of academic impact, for papers by D Pometta Breakdown of academic impact, for papers by Patrick I. Eacho Breakdown of academic impact, for papers by Willeke de Haan Breakdown of academic impact, for papers by Lauren M. Cagen
Rankless by CCL
2026